Development of diagnosis and treatment strategy for breast cancer based on molecular classification

Development of diagnosis and treatment strategy for breast cancer based on molecular classification - Development of diagnosis and treatment strategy for breast cancer

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000038962

Enrollment

2100

Registered

2020-01-01

Start date

2013-08-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer and benign breast disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Breast cancer patients treated with operation and obtained written informed consent. Patients with metastatic breast cancer and benign breast disease are also incorporated.

Exclusion criteria

Exclusion criteria: Patients who do not received any treatment and patients without written informed consent.

Design outcomes

Primary

Measure	Time frame
Identification of factors which predict prognosis and treatment efficacy.	—

Countries

Japan

Contacts

Public ContactMasafumi Shimoda

Hyogo Medical University Division of Breast and Endocrine Surgery

shimoda@hyo-med.ac.jp0798456374

Outcome results